Keyphrases
COVID-19
100%
Depok
68%
Pandemi
68%
Webinar
68%
Hospital Preparedness
68%
Saliva
27%
Without Diabetes
24%
Tuberculous Meningitis
22%
Patients with COVID-19
22%
Indonesia
21%
Periodontitis
18%
Quantitative PCR
17%
Sputum
16%
Aggregatibacter Actinomycetemcomitans
15%
Patients with Diabetes
15%
HIV Patients
14%
Randomized Placebo-controlled Trial
13%
Angiotensin-converting Enzyme 2 (ACE2)
12%
Pulmonary Tuberculosis
12%
Salivary C-reactive Protein
11%
Urine Lipoarabinomannan
11%
AIDS/HIV
11%
Mycobacterial Species
11%
RNA Exosome
11%
Rifampicin
11%
Mycobacterium Tuberculosis (M. tb)
11%
Modul
11%
Lipoarabinomannan
11%
High Dose
11%
Phase II Trial
11%
Crystal Violet
11%
Biofilm
11%
MicroRNA-155 (miR-155)
11%
Counseling
11%
Interleukin-6
11%
HIV Drug Resistance
11%
Inflammatory Markers
11%
Loop-mediated Isothermal Amplification
11%
Porphyromonas Gingivalis (P. gingivalis)
11%
Helicobacter Pylori Infection
11%
Candida Albicans (C. albicans)
11%
Knowledge Level
11%
Acinetobacter Baumannii (A. baumannii)
11%
Presentation Management
11%
Medical Students
11%
Non-invasive Measurement
11%
Jakarta
11%
Soft Tissue
11%
Reverse Transcription Loop-mediated Isothermal Amplification (RT-LAMP)
11%
Faculty of Medicine
11%
Medicine and Dentistry
COVID-19
57%
Diabetes
35%
Human Immunodeficiency Virus
25%
Angiotensin Converting Enzyme 2
22%
Infection
20%
Periodontitis
20%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Real-Time Polymerase Chain Reaction
15%
Sputum
14%
Serositis
13%
Aggregatibacter Actinomycetemcomitans
12%
Porphyromonas gingivalis
12%
Interleukin 6
11%
Loop-Mediated Isothermal Amplification
11%
C Reactive Protein
11%
Non Invasive Measurement
11%
Atypical Mycobacterium
11%
Lipoarabinomannan
11%
Central Nervous System Infection
11%
Tuberculous Meningitis
11%
Pylorus
11%
Helicobacter Infection
11%
microRNA 155
11%
Drug Megadose
11%
Rifampicin
11%
Placebo
11%
Acinetobacter Baumannii
11%
Crystal Violet
11%
Prospective Cohort Study
11%
Gene Expression
11%
Diabetes Mellitus
11%
Disease
9%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Reverse Transcription Loop Mediated Isothermal Amplification
8%
Sensitivity and Specificity
7%
Complement Component C3
7%
Patient with Diabetes
7%
Rutin
5%
Prolene
5%
P. Gingivalis
5%
Prevalence
5%
Dysbiosis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Midazolam
68%
Infection
24%
Periodontitis
24%
Tuberculous Meningitis
22%
Placebo
21%
HIV
20%
Acinetobacter Baumannii
17%
SARS Coronavirus
16%
Disease
15%
Inflammation
15%
Coronavirinae
13%
Porphyromonas gingivalis
13%
Diabetes Mellitus
12%
C Reactive Protein
11%
Interleukin 6
11%
microRNA 155
11%
Congenital Disorder
11%
Parasitosis
11%
HIV Drug Resistance
11%
Tic
11%
Cross-Sectional Study
11%
Candida Albicans
11%
Dexamethasone
11%
Crystal Violet
11%
Rifampicin
11%
Agar
11%
Angiotensin Converting Enzyme 2
11%
Gingivitis
6%
Protein
5%
Zidovudine
5%
Candida Tropicalis
5%
Rutin
5%
Polypropylene
5%
Klebsiella pneumoniae
5%
Suppuration
5%
Aspergillus
5%
Lama
5%
